NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026)

NeuroPace's (NPCE) quarterly Amortization of Deferred Charges came in at $68000.0 in Q1 2026, up 38.78% year-on-year from $49000.0 in Q1 2025, and up 106.6% quarter-over-quarter from -$1.0 million in Q4 2025.

NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

NeuroPace's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $68000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 38.78% year-over-year to $68000.0 in Q1 2026; TTM through Mar 2026 was -$863000.0, a 232.36% decrease from a year earlier, with the FY2025 full-year figure at $237000.0, down 84.83% from the prior year.
  • Amortization of Deferred Charges advanced to $68000.0 in Q1 2026 per NPCE's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $403000.0 in Q4 2024 and bottomed at -$1.8 million in Q4 2022.
  • The 5-year median for Amortization of Deferred Charges is $100000.0 (2022), against an average of -$44187.5.
  • Across the five-year window, Amortization of Deferred Charges slumped 782.0% in 2022 and jumped 430.26% in 2024, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at -$1.8 million in 2022, then jumped by 104.31% to $76000.0 in 2023, then soared by 430.26% to $403000.0 in 2024, then tumbled by 355.83% to -$1.0 million in 2025, then jumped by 106.6% to $68000.0 in 2026.
  • Per Business Quant, the three latest NPCE Amortization of Deferred Charges figures stand at $68000.0 (Q1 2026), -$1.0 million (Q4 2025), and $100000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 NeuroPace 494.96 Mn 440.98 Mn 18.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68,000.00
Mar 31, 2026 68,000.00
Dec 31, 2025 -1.03 Mn
Dec 31, 2025 -1.03 Mn
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 49,000.00
Mar 31, 2025 49,000.00
Dec 31, 2024 403,000.00
Dec 31, 2024 403,000.00
Sep 30, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 378,000.00
Mar 31, 2024 378,000.00
Dec 31, 2023 76,000.00
Dec 31, 2023 76,000.00
Sep 30, 2023 100,000.00
Sep 30, 2023 100,000.00